Prevalence and associated factors of mother-reported jaundice in newborns.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Associação Médica Brasileira Country of Publication: Brazil NLM ID: 9308586 Publication Model: eCollection Cited Medium: Internet ISSN: 1806-9282 (Electronic) Linking ISSN: 01044230 NLM ISO Abbreviation: Rev Assoc Med Bras (1992) Subsets: MEDLINE
    • Publication Information:
      Original Publication: São Paulo : Associação Médica Brasileira
    • Subject Terms:
      Jaundice, Neonatal*/epidemiology; Humans ; Infant, Newborn ; Female ; Prevalence ; Cross-Sectional Studies ; Pregnancy ; Risk Factors ; Male ; Brazil/epidemiology ; Adult ; Socioeconomic Factors ; Mothers/statistics & numerical data ; Young Adult
    • Abstract:
      Objective: Newborns' jaundice is the result of bilirubin accumulation as fetal hemoglobin is metabolized by the immature liver. This study aimed to estimate the prevalence of mother-reported newborn jaundice and associated factors.
      Methods: A cross-sectional study was carried out using data from a longitudinal study involving 914 children. The data were reviewed using Poisson regression with a robust estimator in a hierarchical model in which the sociodemographic variables constituted the first level, those related to the conditions of the pregnancy constituted the second level, and those related to the report of jaundice, the third level. Prevalence ratios and their relevant confidence intervals were estimated.
      Results: The prevalence of reported jaundice in newborns was 17.9%. The variables late pregnancy, urinary infection during pregnancy, and preterm and post-term birth were independently statistically associated with a higher prevalence of newborn jaundice reports.
      Conclusion: We can conclude that mother-reported newborn jaundice was 17.9% associated with maternal and birth aspects.
    • References:
      AIDS Rev. 2006 Jan-Mar;8(1):24-36. (PMID: 16736949)
      J Matern Fetal Neonatal Med. 2022 Dec;35(25):9201-9207. (PMID: 34957902)
      Ginekol Pol. 2022;93(2):134-141. (PMID: 35072250)
      Am Fam Physician. 2023 May;107(5):525-534. (PMID: 37192079)
      World J Pediatr. 2021 Jun;17(3):290-297. (PMID: 34047994)
      Sci Rep. 2022 Aug 23;12(1):14385. (PMID: 35999237)
      Semin Fetal Neonatal Med. 2012 Jun;17(3):126-31. (PMID: 22317884)
      Semin Perinatol. 2021 Feb;45(1):151351. (PMID: 33308896)
      Pak J Biol Sci. 2008 Mar 15;11(6):942-5. (PMID: 18814662)
      Eur J Obstet Gynecol Reprod Biol. 2020 Apr;247:212-218. (PMID: 32146227)
      Cochrane Database Syst Rev. 2023 May 9;5:CD012660. (PMID: 37158489)
      Eur J Pediatr. 2021 May;180(5):1603-1610. (PMID: 33469713)
      Drug Chem Toxicol. 2014 Apr;37(2):121-9. (PMID: 24099411)
      Afr J Prim Health Care Fam Med. 2018 Apr 12;10(1):e1-e6. (PMID: 29781686)
      Clin Perinatol. 2016 Jun;43(2):297-311. (PMID: 27235209)
      An Acad Bras Cienc. 2018 Jul-Sep;90(3):3105-3114. (PMID: 30304238)
      Lancet Child Adolesc Health. 2018 Aug;2(8):610-620. (PMID: 30119720)
      Neoreviews. 2020 Nov;21(11):e749-e760. (PMID: 33139512)
      Curr Pediatr Rev. 2017;13(3):199-209. (PMID: 28814249)
    • Publication Date:
      Date Created: 20241030 Date Completed: 20241030 Latest Revision: 20241101
    • Publication Date:
      20241101
    • Accession Number:
      PMC11509175
    • Accession Number:
      10.1590/1806-9282.20240691
    • Accession Number:
      39475918